1. FDA submissions P080003, P080003/S001, P080003/S004, P080003/S005
  2. Friedwald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25; 311(24):2499–507.
  3. Zuckerman SP, Conant EF, Keller BM, et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology. 2016 Dec; 281(3):730–736.
  4. Skaane P, Bandos A, Eben EB, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital tomosynthesis with full-field digital mammographic images. Radiology. 2014 June; 271(3):655–63.
  5. Bernardi D, Macaskill P, Pellegrini M, et al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug; 17(8):1105–13.
  6. McDonald ES, Oustimov A, Weinstein SP, et al. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening. JAMA Oncol. 2016 June 1; 2(6):737–43.
  7. Smith, A. Improving Patient Comfort in Mammography. Hologic WP-00119 Rev 001 (2017).
  8. Hologic Data on file, 2017.